Chemical Compound
Pindolol; 2-Propanol, 1-(indol-4-yloxy)-3-(isopropylamino)- (8CI); 1-(1H-Indol-4-yloxy)-3-[(1-methylethyl)amino]-2-propanol; (RS)-Pindolol; (+/-)-4-[2-Hydroxy-3-(isopropylamino)propoxy]indole; (+/-)-LB 46; (+/-)-Pindolol; 1-[(1-Methylethyl)amino]-3-(4-indolyloxy)-2-propanol; 4-(2-Hydroxy-3-isopropylaminopropoxy)indole; 4-(3-Isopropylamino-2-hydroxypropoxy)indole; Apo-pindol; Betapindol; Blocklin L; Calvisken; Carvisken; DL-4-[2-Hydroxy-3-(isopropylamino)propoxy]indole; DL-LB 46; DL-Pindolol; Decreten; Durapindol; Glauco-Visken; LB 46; LB 46 (pharmaceutical); N-[2-Hydroxy-3-(1H-indol-4-yloxy)propyl]-N-isopropylamine; Pectobloc; Pinbetol; Prinodolol; Pynastin; Visken; dl-Pindolol
CAS Registry Number
13523-86-9
Primary record
Pindolol; 2-Propanol, 1-(indol-4-yloxy)-3-(isopropylamino)- (8CI); 1-(1H-Indol-4-yloxy)-3-[(1-methylethyl)amino]-2-propanol; (RS)-Pindolol; (+/-)-4-[2-Hydroxy-3-(isopropylamino)propoxy]indole; (+/-)-LB 46; (+/-)-Pindolol; 1-[(1-Methylethyl)amino]-3-(4-indolyloxy)-2-propanol; 4-(2-Hydroxy-3-isopropylaminopropoxy)indole; 4-(3-Isopropylamino-2-hydroxypropoxy)indole; Apo-pindol; Betapindol; Blocklin L; Calvisken; Carvisken; DL-4-[2-Hydroxy-3-(isopropylamino)propoxy]indole; DL-LB 46; DL-Pindolol; Decreten; Durapindol; Glauco-Visken; LB 46; LB 46 (pharmaceutical); N-[2-Hydroxy-3-(1H-indol-4-yloxy)propyl]-N-isopropylamine; Pectobloc; Pinbetol; Prinodolol; Pynastin; Visken; dl-Pindolol
- 库存
- 727 克
- 纯度
- 99.6 %
- CAS
- 13523-86-9
化合物标识与属性
- CAS
- 13523-86-9
- PubChem CID
- 4828
- SMILES
- CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
- Canonical SMILES
- CC(C)NCC(O)COc1cccc2[nH]ccc12
名称与同义词
- pindolol
- Visken
- Prinodolol
- Betapindol
- Carvisken
- Durapindol
- Calvisken
- Pinbetol
- Pectobloc
- Decreten
- Pynastin
- Blocklin L
- Glauco-visken
- Pindololum
- Blocklin-L
- DL-Pindolol
- Prindolol
- 13523-86-9
- Glauco-Viskin
- Apo-pindol
- Cardilate
- Blockin L
- (rs)-pindolol
- Blocklin
- Viskazide
- l-Pindolol
- LB-46
- pindololo
- terazosin
- Barusamizin
- Keivisken
- Pithiorol
- Viringal
- Youvisken
- Isuhart
- (+-)-Pindolol
- Pindolol-d7
- Osnon
- Prindolol;
- Carvisken (TN)
- (-)-pindolol
- Let-lit
- Pindolol CRS
- Blocklin-L (TN)
- Pindololum [INN-Latin]
- Visken (TN)
- Betapindol (TN)
- Durapindol (TN)
- Calvisken (TN)
- Cardilate (TN)
- Pectobloc (TN)
- Prindolol (TN)
- Decreten (TN)
- Pinbetol (TN)
- Pynastin (TN)
- (+)-pindolol
- Prestwick_397
- LB 46
- Dl-lb-46
- Blocklin L (TN)
- S(-)-Pindolol
- Pindolol (Standard)
- (S)-(-)-pindolol
- Blockin L (TN)
- BJ4HF6IU1D
- Glauco-Visken (TN)
- D-PINDOLOL
- UNII-BJ4HF6IU1D
- Spectrum_001109
- (R)-(+)-pindolol
- PINDOLOL [HSDB]
- PINDOLOL [USAN]
- RefChem:55861
- C14H20N2O2
- DTXSID8023476
- PINDOLOL [INN]
- PINDOLOL [JAN]
- PINDOLOL [MI]
- PINDOLOL [VANDF]
- (.+/-.)-Pindolol
- Prestwick0_000090
- Prestwick1_000090
- Prestwick2_000090
- Prestwick3_000090
- Spectrum2_001285
- Spectrum3_000547
- Spectrum4_000479
- Spectrum5_001266
- CCRIS 9215
- LB46
- (R,S)-PINDOLOL
- JZQKKSLKJUAGIC-UHFFFAOYSA-N
- PINDOLOL [MART.]
- CHEMBL500
- D0F2PO
- GTPL91
- PINDOLOL [USP-RS]
- PINDOLOL [WHO-DD]
- PINDOLOL,(-)
- HSDB 6539
- AC1L1J1N
- AC1Q1QC1
- Pindolol [USAN:INN:BAN:JAN]
- SCHEMBL5219
- 4-(2-Hydroxy-3-isopropylaminopropoxy)-indole
- CHEBI:8214
- DL-LB 46
- DTXCID603476
- Lopac0_000955
- Oprea1_770884
- (+/-)-PINDOLOL
- BSPBio_000020
- BSPBio_002193
- KBioGR_000958
- KBioSS_001589
- MLS000069496
- MLS002548891
- DivK1c_000837
- NSC-757276
- SPECTRUM1500488
- EINECS 236-867-9
- EINECS 244-623-8
- Pindolol (JP15/USP/INN)
- Pindolol (JP18/USP/INN)
- SPBio_001289
- SPBio_001959
- 1-(Indol-4-yloxy)-3-(isopropylamino)-2-propanol
- PINDOLOL [ORANGE BOOK]
- BPBio1_000022
- orb2703260
- orb3029220
- PINDOLOL [EP MONOGRAPH]
- PINDOLOL [USP MONOGRAPH]
- SCHEMBL29908300
- 1-(1H-indol-4-yloxy)-3-(isopropylamino)propan-2-ol
- CTK8G2432
- ERK5-2L22
- HMS502J19
- HY-B0982R
- KBio1_000837
- KBio2_001589
- KBio2_004157
- KBio2_006725
- KBio3_001693
- BRN 1536506
- C07AA03
- CID4828
- Pindolol [USAN:BAN:INN:JAN]
- MFCD00010530
- NINDS_000837
- 1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol
- 1-(1H-Indol-4-yloxy)-3-[(1-methylethyl)amino]-2-propanol
- 4-(3-(Isopropylamino)-2-hydroxypropoxy)indole
- HMS1568A22
- HMS1920H16
- HMS2089I21
- HMS2091P20
- HMS2095A22
- HMS3259I07
- HMS3262P12
- HMS3267K17
- HMS3369E14
- HMS3414J03
- HMS3678H21
- HMS3712A22
- HMS3742C07
- HMS3885N04
- HMS5083C21
- Pharmakon1600-01500488
- Pindolol [USAN:USP:INN:BAN:JAN]
- VISKAZIDE COMPONENT PINDOLOL
- (+-)-lb46
- 1-((1-Methylethyl)amino)-3-(4-indolyloxy)-2-propanol
- CID:4828
- HY-B0982
- MSK10061
- 2-(1H-pyrazol-1-yl)propan-1-ol
- C14-H20-N2-O2.Cl-H
- EINECS 249-250-4
- Pindolol, >=98% (TLC), powder
- Tox21_110221
- Tox21_500955
- BDBM50019443
- CCG-39223
- EBC-26316
- NCGC00015786-11
- NSC757276
- PDSP1_000771
- PDSP1_000772
- PDSP2_000759
- PDSP2_000760
- AKOS015969756
- C14-H20-N2-O2
- Tox21_110221_1
- CS-4473
- DB00960
- J3.439H
- LP00955
- NC00467
- NSC 757276
- SB17015
- SDCCGSBI-0050929.P005
- (A+-)-LB-46
- 1-(1H-Indol-4-yloxy)-3-((1-methylethyl)amino)-2-propanol
- 2-Propanol, 1-(4-indolyloxy)-3-(isopropylamino)-
- IDI1_000837
- 2-Propanol, 1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]-
- NCGC00015786-06
- NCGC00015786-07
- NCGC00015786-08
- NCGC00015786-09
- NCGC00015786-10
- NCGC00015786-13
- NCGC00015786-14
- NCGC00015786-16
- NCGC00015786-20
- NCGC00015786-22
- NCGC00024925-03
- NCGC00024925-04
- NCGC00024925-05
- NCGC00024925-06
- NCGC00024925-07
- NCGC00261640-01
- (+/-)-LB-46
- 1-(1H-Indol-4-yloxy)-3-(isopropylamino)-2-propanol
- AN-18448
- BS-42390
- CPD000059120
- DA-66729
- SAM002264631
- SC-25688
- SID:53787727
- SMR000059120
- 1-((1H-indol-4-yl)oxy)-3-(isopropylamino)propan-2-ol
- P 0778
- SBI-0050929.P004
- 1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)-propan-2-ol
- 2-Propanol, 1-(1H-indol-4-yloxy)-3-((1-methylethyl)amino)-
- CAS-13523-86-9
- J246.149H
- J457.020K
- LS-122385
- 1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]propan-2-ol
- 4-(3-Isopropylamino-2-hydroxypropoxy)indole
- AB00052072
- EU-0100955
- NS00007947
- ST50319990
- SW196641-3
- Z3376
- 5-21-03-00017 (Beilstein Handbook Reference)
- DL-4-[2-Hydroxy-3-(isopropylamino)propoxy]indole
- 4-[2-hydroxy-3-(isopropylamino)propoxy]indole
- C07445
- C90604
- D00513
- P-6820
- (-)-Pindolol; (S)-(-)-Pindolol; S-Pindolol
- (1)-1-(1H-Indol-4-yloxy)-3-(isopropylamino)propan-2-ol
- 1-(1H-indol-4-yloxy)-3-[(propan-2-yl)amino]propan-2-ol
- 2-Propanol, 1-(1H-indol-4-yloxy)-3-(1-methylethyl)amino-
- 2-Propanol, 1-(indol-4-yloxy)-3-(isopropylamino)-
- AB00052072-11
- AB00052072_12
- AB00052072_13
- 1-(4-Indolyloxy)-3-(isopropylamino)-2-propanol
- 2-Propanol, 1-(indol-4-yloxy)-3-(isopropylamino)-, (+-)-
- 523P869
- A937958
- D010869
- EN300-18518413
- L000006
- Q418101
- SR-01000000027
- 3-indol-4-yloxy-1-[(methylethyl)amino]propan-2-ol
- 4-(2-HYDROXY-3-ISOPROPYLAMINOPROPOXY)INDOLE
- SR-01000000027-2
- SR-01000000027-4
- SR-01000000027-5
- SR-01000000027-7
- (+-)-4-(2-hydroxy-3-(isopropylamino)propoxy)indole
- 1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol
- 1-[1H-INDOL-4-YLOXY]-3-[ISOPROPYLAMINO]-2-PROPANOL
- BRD-A97701745-001-05-3
- BRD-A97701745-001-09-5
- BRD-A97701745-001-14-5
- BRD-A97701745-001-15-2
- BRD-A97701745-001-16-0
- (+)-1-(1H-Indol-4-yloxy)-3-isopropylamino-2-propanol
- 1-(1H-Indol-4-yloxy)-3-(isopropylamino)-2-propanol #
- 26328-11-0
- Pindolol, European Pharmacopoeia (EP) Reference Standard
- (-)-1-(1H-Indol-4-yloxy)-3-(isopropylamino)-2-propanol
- 1-(1h-indol-4-yloxy)-3-((1-methylethyl)amino)-2-propano
- 1-(1H-indol-4-yloxy)-3-((propan-2-yl)amino)propan-2-ol
- DL-4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)INDOLE
- N-Isopropyl-3-(1H-indol-4-yloxy)-2-hydroxypropan-1-amine
- (+)-1-[(1H-Indol-4-yl)oxy]-3-(isopropylamino)-2-propanol
- (+-)-1-(1H-indol-4-yloxy)-3-(isopropylamino)propan-2-ol
- (+/-)-4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)INDOLE
- 1-(1H-indol-4-yloxy)-3-((1-methylethyl)amino)propan-2-ol
- 1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol(pindolol)
- 1-[(1H-Indol-4-yl)oxy]-3-[(propan-2-yl)amino]propan-2-ol
- 2-propanol, 1-(1H-indol-4-iloxi)-3-[(1-metiletil) amino]-
- Pindolol, United States Pharmacopeia (USP) Reference Standard
- (-)-1-[(1H-Indol-4-yl)oxy]-3-[(1-methylethyl)amino]-2-propanol
- (2RS)-1-(1H-Indol-4-yloxy)-3-(1-methylethyl)aminopropan-2-ol
- 1-(1,1,1,2,3,3,3-heptadeuteriopropan-2-ylamino)-3-(1H-indol-4-yloxy)propan-2-ol
- 1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol((-)-Pindolol)
- N-(2-HYDROXY-3-(1H-INDOL-4-YLOXY)PROPYL)-N-ISOPROPYLAMINE
- 1-(1H-Indol-4-yloxy)-3-(isopropylamino)propan-2-ol monohydrochloride
- 1185031-19-9
- 236-867-9
- 28813-39-0
- Pindolol; 2-Propanol, 1-(indol-4-yloxy)-3-(isopropylamino)- (8CI); 1-(1H-Indol-4-yloxy)-3-[(1-methylethyl)amino]-2-propanol; (RS)-Pindolol; (+/-)-4-[2-Hydroxy-3-(isopropylamino)propoxy]indole; (+/-)-LB 46; (+/-)-Pindolol; 1-[(1-Methylethyl)amino]-3-(4-indolyloxy)-2-propanol; 4-(2-Hydroxy-3-isopropylaminopropoxy)indole; 4-(3-Isopropylamino-2-hydroxypropoxy)indole; Apo-pindol; Betapindol; Blocklin L; Calvisken; Carvisken; DL-4-[2-Hydroxy-3-(isopropylamino)propoxy]indole; DL-LB 46; DL-Pindolol; Decreten; Durapindol; Glauco-Visken; LB 46; LB 46 (pharmaceutical); N-[2-Hydroxy-3-(1H-indol-4-yloxy)propyl]-N-isopropylamine; Pectobloc; Pinbetol; Prinodolol; Pynastin; Visken; dl-Pindolol